Amarenco P, Bogousslavsky J, et al. High-dose atorvastatin after stroke or transient ischemic attack.
N Engl J Med. 2006;355:549-559.
Grundy SM, Cleeman JL, et al. National Heart, Lung, and Blood Institute, American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guidelines.
Lemaitre RN, Psaty B, et al. Therapy with hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults.
Arch Intern Med. 2002;162:1395-1400.
Lipid-lowering pharmacotherapy overview. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated September 12, 2014. Accessed December 11, 2014.
Middleton A, Binbrek AS, et al. Achieving 2003 European lipid goals with rosuvastatin and comparator statins in 6,743 patients in real-life clinical practice: DISCOVERY meta-analysis.
Curr Med Res Opin. 2006;22: 1181-1191.
Statins. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated November 4, 2014. Accessed December 11, 2014.
Statins. Food and Drug Administration website. Available at: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm294358.htm. Updated November 21, 2012. Accessed December 11, 2014.
Statin drugs. EBSCO Natural and Alternative Treatments website. Available at: http://www.ebscohost.com/biomedical-libraries/natural-alternative-treatments. Updated September 18, 2014. Accessed December 11, 2014.
Statins for prevention of cardiovascular disease. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated September 15, 2014. Accessed December 11, 2014.
Stender S, Schuster H, et al. Comparison of rosuvastatin with atorvastatin, simvastatin, and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
Diabetes Obes Metab.
Tahara N, Kai H, et al. Simvastatin attenuates plaque inflammation: evaluation by fuorodeoxyglucose positron emission tomography.
J Am Coll Cardiol. 2006;48:1825-1831.
1/30/2009 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: Mills EJ, Rachlis B, et al. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
J Am Coll Cardiol.
3/6/2012 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: FDA announces safety changes in labeling for some cholesterol-lowering drugs. US Food and Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm293623.htm. Updated March 2, 2012. Accessed December 11, 2014.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.